GSK3B and Alzheimer disease: Upon RhoA/ROCK dysregulation, the hyperactivation of GSK3β has been well demonstrated to be a major contributor to the pathogenesis of AD, largely by phosphorylating tubulin-associated units (tau) [125,126,127].